-
Another coronavirus vaccine in China will enter clinical trials
Phase I/II clinical trials of the new coronavirus (COVID-19) inactivated vaccine (Vero cells) developed by Sinopharm Group China Wuhan Bioproducts Research Institute Co., Ltd. are in pre-registration of "passed review" at the China Clinical Trial Registration Center status.
-
Huawei says disrupting its involvement in 5G rollout would do Britain a disservice
Chinese telecoms giant Huawei said that disrupting its involvement in the rollout of 5G would do Britain "a disservice".
-
China-made UOS completes adaptation with Ricoh multifunction printers
The Unity Operating System (UOS) and major models of Ricoh Multifunction Printers have completed compatibility adaption, Union Tech, the company behind the UOS said today.
-
Explainer: What is asymptomatic infection
At present, the spread of new local coronavirus in China has been basically stopped, but the asymptomatic infection of new coronavirus has attracted much attention.
-
Snapdragon 865 tops Master Lu's Q1 mobile phone processor rankings
The performance list released by Master Lu today shows that the Snapdragon 865, Snapdragon 855 Plus, and Kirin 990 5G are the top three.
-
China's mobile phone shipments decreased by 23.3% year-on-year in March
In March, the overall shipments of the Chinese mobile phone market were 21.756 million, a year-on-year decrease of 23.3%, according to the China Academy of Information and Communications Technology.
-
Xpeng establishes trading firm with registered capital of 10 million yuan
On April 9, Xpeng Motors established Guangzhou Xpeng Trading Co., Ltd. as a wholly-owned subsidiary, according to data from Tianyancha.
-
Apple will introduce Xcode to iOS 14 and iPadOS 14, report says
Apple is currently working hard to introduce Xcode into iOS 14 and iPad OS 14, 9TechEleven quoted well-known leaker Jon Prosser as saying.
-
TikTok marks 1 billion downloads in Google Play Store
TikTok's downloads in the Google Play store have exceeded 1 billion.
-
What role does immunity play in treatment of Covid-19?
On the evening of April 9, Cao Xuetao, academician of the Chinese Academy of Engineering and president of Nankai University, published a review article entitled "Immunopathology of New Coronavirus Pneumonia and Its Implications for Treatment" in the "Nature-Immunology Review" online.